Easterly Investment Partners LLC Allakos Inc. Transaction History

Easterly Investment Partners LLC

  • $1.25 Billion
  • Q4 2024

A detailed history of Easterly Investment Partners LLC transactions in Allakos Inc. stock. As of the latest transaction made, Easterly Investment Partners LLC holds 25,000 shares of ALLK stock, worth $7,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,000
Previous 25,000 -0.0%
Holding current value
$7,500
Previous $16,000 87.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$3.02 - $6.12 $75,500 - $153,000
-25,000 Reduced 50.0%
25,000 $153,000
Q4 2021

Feb 08, 2022
BUY
$8.55 - $111.89 $427,500 - $5.59 Million
50,000 New
50,000 $490,000

Others Institutions Holding ALLK

# of Institutions
79
Shares Held
68.8M
Call Options Held
20.9K
Put Options Held
0
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $25.4M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Easterly Investment Partners LLC Portfolio

Follow Easterly Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email